Skip to content

Biofrontera Inc.

BFRI BFRIW

CIK 0001858685 · Pharmaceutical Preparations · Nasdaq, Nasdaq

← back to feed
Revenue (TTM)
$34.69M
+11.7% YoY Q1 May 2026
Net Income (TTM)
−$20.93M
+40.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.07
+67.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-58.3%
Q1 May 2026
Net Margin
-60.3%
Q1 May 2026
Free Cash Flow (TTM)
−$11.28M
Q1 May 2026
Cash
$6.32M
Q1 May 2026
Total Debt
$296K
Q1 May 2026
Shares Outstanding
12.8M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings